Evolus (EOLS)
(Delayed Data from NSDQ)
$12.93 USD
+0.32 (2.54%)
Updated May 31, 2024 04:00 PM ET
After-Market: $12.93 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EOLS 12.93 +0.32(2.54%)
Will EOLS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for EOLS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EOLS
Evolus (EOLS) Releases Favorable Dermal Fillers Study Data
Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates
EOLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
4 Stocks to Keep a Tab on for Amazing Earnings Acceleration
Green Thumb Industries Inc. (GTBIF) Surges 22.3%: Is This an Indication of Further Gains?
3 Top Stocks to Invest in for Amazing Earnings Acceleration
Other News for EOLS
Evolus: Chiseling Away At The Aesthetic Market
Barclays Reaffirms Their Buy Rating on Evolus (EOLS)
Evolus: Chiseling Away At The Aesthetic Market
3 Best Stocks to Buy Now, 5/22/2024, According to Top Analysts
Strong Buy Rating for Evolus Backed by Growth Potential and Market Penetration Prospects